cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.5517/ccdc.csd.cc2c68d8
title: CCDC 2180769: Experimental Crystal Structure Determination

description: Related Article: Maximilian Moxter, Michael Bolte, Matthias Wagner|2022|CSD Communication|||
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2c68f9
title: CCDC 2180770: Experimental Crystal Structure Determination

description: Related Article: Maximilian Moxter, Michael Bolte, Matthias Wagner|2022|CSD Communication|||
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2c68hc
title: CCDC 2180772: Experimental Crystal Structure Determination

description: Related Article: Maximilian Moxter, Michael Bolte, Matthias Wagner|2022|CSD Communication|||
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2c68jd
title: CCDC 2180773: Experimental Crystal Structure Determination

description: Related Article: Maximilian Moxter, Michael Bolte, Matthias Wagner|2022|CSD Communication|||
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5281/zenodo.6808533
title: Data from: Vibrational Transportation on a Platform Subjected to Sinusoidal Displacement Cycles Employing Dry Friction Control

description: Data from the paper "Vibrational Transportation on a Platform Subjected to Sinusoidal Displacement Cycles Employing Dry Friction Control", https://doi.org/10.3390/s21217280 Currently used vibrational transportation methods are usually based on asymmetries of geometric, kinematic, wave, or time types. This paper investigates the vibrational transportation of objects on a platform that is subjected to sinusoidal displacement cycles, employing periodic dynamic dry friction control. This manner of dry friction control creates an asymmetry, which is necessary to move the object. The theoretical investigation on functional capabilities and transportation regimes was carried out using a developed parametric mathematical model, and the control parameters that determine the transportation characteristics such as velocity and direction were defined. To test the functional capabilities of the proposed method, an experimental setup was developed, and experiments were carried out. The results of the presented research indicate that the proposed method ensures smooth control of the transportation velocity in a wide range and allows it to change the direction of motion. Moreover, the proposed method offers other new functional capabilities, such as a capability to move individual objects on the same platform in opposite directions and at different velocities at the same time by imposing different friction control parameters on different regions of the platform or on different objects. In addition, objects can be subjected to translation and rotation at the same time by imposing different friction control parameters on different regions of the platform. The presented research extends the classical theory of vibrational transportation and has a practical value for industries that operate manufacturing systems performing tasks such as handling and transportation, positioning, feeding, sorting, aligning, or assembling.
description: This research was funded by a grant (No. S-MIP-19-64) from the Research Council of Lithuania
DOI: 10.25934/00007027
title: A Pilot Trial Of Escalating Doses Of Oral ZD1839 (Iressa) In Combination With Mitoxantrone And Prednisolone In Patients With Hormone Refractory Prostate Cancer.

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.5281/zenodo.6808532
title: Data from: Vibrational Transportation on a Platform Subjected to Sinusoidal Displacement Cycles Employing Dry Friction Control

description: Data from the paper "Vibrational Transportation on a Platform Subjected to Sinusoidal Displacement Cycles Employing Dry Friction Control", https://doi.org/10.3390/s21217280 Currently used vibrational transportation methods are usually based on asymmetries of geometric, kinematic, wave, or time types. This paper investigates the vibrational transportation of objects on a platform that is subjected to sinusoidal displacement cycles, employing periodic dynamic dry friction control. This manner of dry friction control creates an asymmetry, which is necessary to move the object. The theoretical investigation on functional capabilities and transportation regimes was carried out using a developed parametric mathematical model, and the control parameters that determine the transportation characteristics such as velocity and direction were defined. To test the functional capabilities of the proposed method, an experimental setup was developed, and experiments were carried out. The results of the presented research indicate that the proposed method ensures smooth control of the transportation velocity in a wide range and allows it to change the direction of motion. Moreover, the proposed method offers other new functional capabilities, such as a capability to move individual objects on the same platform in opposite directions and at different velocities at the same time by imposing different friction control parameters on different regions of the platform or on different objects. In addition, objects can be subjected to translation and rotation at the same time by imposing different friction control parameters on different regions of the platform. The presented research extends the classical theory of vibrational transportation and has a practical value for industries that operate manufacturing systems performing tasks such as handling and transportation, positioning, feeding, sorting, aligning, or assembling.
description: This research was funded by a grant (No. S-MIP-19-64) from the Research Council of Lithuania
DOI: 10.25934/00006962
title: Nebulised budesonide for the treatment of croup(acute laryngotracheobronchitis)in childhood.Efficacy and safety study of therapy and prophylaxis of recurrence with nebulized budesonide for children with croup.\n\t\t\t\t

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006963
title: An assessment of treatment preference by asthmatics comparing pMDI to Pulmicort Turbuhaler

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00007007
title: A phase II, multi-centre trial to assess the efficacy of ZD1839 (IRESSATM) 500 mg/day in patients with selected, EGFR+ solid tumours who have failed at least one previous chemotherapy regimen for advanced disease.

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00007002
title: A Phase II, randomised, double blind placebo controlled study to evaluate the impact of late onset gefitinib (ZD1839) on the occurrence of distant metastases in patients with potentially curatively treated locally advanced non small cell lung cancer (NSCLC)

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006992
title: A Phase II trial to evaluate the efficacy of Iressa and Target inhibition of EGFR in adenonocarcinoma of the oesophagus

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00007053
title: The impact of different delivery systems on the dosage of nebulised budesonide for children

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006996
title: An open label non comparative phase II trial of ZD1839 (Iressa) in patients with advanced or metastatic hormone refractory prostate cancer

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006998
title: A phase II trial to evaluate the combination of paclitaxel (TAXOL) with ZD1839 (Iressa) in patients with metastatic breast cancer

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006989
title: Assessment of the efficacy of Pulmicort nebulizing suspension for the treatment of exacerbations of chronic obstructive pulmonary disease (COPD) : a multicentre double -blind parallel group study versus prednisolone and placebo

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006987
title: Inhaled budesonide for adults with mild-to-moderate asthma: a randomized placebo-controlled, double-blind clinical trial.

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006999
title: A multicentre open label non comparative phase II trial to evaluate the efficacy and safety of ZD1839 (Iressa) alone as first line treatment in patients with er-negative metastatic breast cancer

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00007009
title: A Phase I/II study to assess the tolerability and efficacy of ZD1839 in combination with radiotherapy in locally advanced inoperable Non Small Cell Lung Cancer (NSCLC)

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00007024
title: An open label non comparative phase II trial to evaluate the efficacy and safety of ZD1839 (Iressa) in patients with locally advanced relapsed or metastatic renal cell carcinoma

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00007057
title: A double-blind, randomized, placebo-controlled, parallel group study to determine the relative efficacy and safety of two different doses of Pulmicort\xae (budesonide) Turbuhaler\xae in patients with chronic asthma not well controlled on Non-steroid therapy.\n

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006994
title: A Phase II trial to evaluate ZD1839 (Iressa) and Docetaxel (Taxotere) combination therapy as first-line treatments in patients with advanced (metastatic) breast cancer

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00007013
title: A phase I dose finding trial of ZD1839 (Iressa) and radiotherapy in untreated patients with locally advanced inoperable squamous cell carcinoma of the head and neck

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006968
title: Nebulised budesonide in the treatment of recurrent obstructive episodes after acute bronchiolitis

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00007000
title: A multicentre, randomised, double-blind, placebo controlled, phase II trial to evaluate the safety and efficacy of ZD1839 (Iressa) in improving prostate-specific antigen control and the clinical course of hormone-refractory prostate cancer

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006986
title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Pulmicort (budesonide) Turbuhaler\xae 400 mcg Administered Once Daily for 12 Weeks, in Adult Patients with Inhaled Steroid-Dependent Asthma

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00007045
title: First line treatment of newly diagnosed asthma: A one year follow-up after two years treatment with either an inhaled steroid, budesonide or a \xdf2-agonist, terbutaline.

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00007056
title: A double-blind, randomized, placebo-controlled study to determine the relative efficacy of four different doses of Pulmicort (budesonide) Turbuhaler in patients with glucocorticosteroid dependent asthma

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006991
title: A randomised phase II and pharmacokinetic study of oral ZD1839 given continuously with oxaliplatin or cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006988
title: Comparison of the efficacy/tolerability of Pulmicort Turbuhaler (budesonide) and placebo in asthmatic children

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.